Iovance Biotherapeutics announces pricing of $219.3 million public offering
Iovance Biotherapeutics announced pricing of an underwritten public offering of 22,000,000 shares of its common stock at a public offering price of $9.97 per share. Iovance has granted underwriters a 30-day option to purchase up to 3,300,000 additional shares of common stock. October 12, 2018